Correspondence 0001062822-24-000049 from LEXICON PHARMACEUTICALS, INC. (LXRX) (CIK 0001062822) (LXRX)

LEXICON PHARMACEUTICALS, INC. (LXRX) (CIK 0001062822)
Date: Aug. 9, 2024 · CIK: 0001062822 · Accession: 0001062822-24-000049

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-281208

Date

August 9, 2024

Author

Not clearly detected

Form

CORRESP

Company

LEXICON PHARMACEUTICALS, INC. (LXRX) (CIK 0001062822)

Letter

VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance Office of Life Sciences Attention: Ms. Lauren Hamill Re: Lexicon Pharmaceuticals, Inc. Form S-3 Registration Statement Filed August 2, 2024 File No. 333-281208

Dear Ms. Hamill:

Lexicon Pharmaceuticals, Inc., a Delaware corporation (the "Company") hereby requests that the effective date of the Company's Registration Statement on Form S-3 (File No. 333-281208) be accelerated under Rule 461 under the Securities Act of 1933, as amended, so that it is declared effective at 4:00 p.m., Eastern time, on August 15, 2024 or as soon thereafter as possible.

Thank you for your attention to this matter and please call the undersigned at (281) 863-3443 with any questions.

Very truly yours,
Lexicon Pharmaceuticals, Inc.

Show Raw Text

CORRESP
1
filename1.htm

Document

[Letterhead of Lexicon Pharmaceuticals, Inc.]

August 9, 2024

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporate Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549-3561

Attention:    Ms. Lauren Hamill

Re:    Lexicon Pharmaceuticals, Inc.

Form S-3 Registration Statement

Filed August 2, 2024

File No. 333-281208

Dear Ms. Hamill:

    Lexicon Pharmaceuticals, Inc., a Delaware corporation (the "Company") hereby requests that the effective date of the Company's Registration Statement on Form S-3 (File No. 333-281208) be accelerated under Rule 461 under the Securities Act of 1933, as amended, so that it is declared effective at 4:00 p.m., Eastern time, on August 15, 2024 or as soon thereafter as possible.

    Thank you for your attention to this matter and please call the undersigned at (281) 863-3443 with any questions.

 Very truly yours,

 Lexicon Pharmaceuticals, Inc.

 By: /s/ BRIAN T. CRUM

  Brian T. Crum

  Senior Vice President and General Counsel

SecProbe.io